Analyst Ratings for Caladrius Biosciences (CLBS)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/22/2020 | Brookline Capital Markets » Updated 3/3/2021 |
Kumaraguru Raja | New Coverage | Buy (N/A) |
10.00 (7.00) |
1.93 (0.43) |
-77.72% | Details |
| 5/18/2020 | Dawson James » Updated 3/23/2022 |
Jason Kolbert | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.83 (0.43) |
-76.5% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
